Alex Pasteur, Phd
Board of Directors
orchard Therapeutics
Switzerland
Biography
Alex Pasteur is a partner at F-Prime Capital based in London, UK. Alex earned a MA in Natural Sciences and a PhD in Chemistry from Cambridge University, and has worked in life sciences since 2001, covering investments in therapeutics and other healthcare sectors. Alex joined F-Prime in 2012 and oversees the European portfolio that currently includes Orchard Therapeutics, Acacia Pharma Limited, Pulmocide Limited and Adaptimmune Therapeutics PLC (NASDAQ: ADAP). He previously worked at MVM Life Science Partners LLP in the USA and Europe and was responsible for investments in Cara Therapeutics Inc., Vantia Ltd and Xention Pharma Ltd.
Research Interest
business
